These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3551506)

  • 1. Is it possible to characterize recurrent urinary stone formers who benefit from thiazide prophylaxis? Application of discrimination analysis.
    Laerum E; Larsen S
    Acta Med Scand; 1987; 221(1):103-8. PubMed ID: 3551506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice.
    Laerum E; Larsen S
    Acta Med Scand; 1984; 215(4):383-9. PubMed ID: 6375276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of thiazide versus placebo in patients under long-term treatment for recurrent urolithiasis.
    Laerum E
    Scand J Urol Nephrol; 1984; 18(2):143-9. PubMed ID: 6463598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unprocessed bran and intermittent thiazide therapy in prevention of recurrent urinary calcium stones.
    Ala-Opas M; Elomaa I; Porkka L; Alfthan O
    Scand J Urol Nephrol; 1987; 21(4):311-4. PubMed ID: 2832935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of thiazide in idiopathic calcium urolithiasis. Results of a one-year double-blind study (author's transl)].
    Scholz D; Schwille PO
    Arzneimittelforschung; 1980; 30(11):1928-32. PubMed ID: 7006616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine therapy in restless legs. Discrimination between responders and non-responders.
    Larsen S; Telstad W; Sørensen O; Thom E; Stensrud P; Nyberg-Hansen R
    Acta Med Scand; 1985; 218(2):223-7. PubMed ID: 3904337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of urinary calculi with thiazides and allopurinol. A long-term study].
    May P; Pilorz H; Duhme C; Pöpperl H; Braun J
    Urologe A; 1984 Mar; 23(2):87-90. PubMed ID: 6426113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.
    Skolarikos A; Straub M; Knoll T; Sarica K; Seitz C; Petřík A; Türk C
    Eur Urol; 2015 Apr; 67(4):750-63. PubMed ID: 25454613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oxalate stone prophylaxis by alkalinizing therapy (author's transl)].
    Butz M
    Urologe A; 1982 May; 21(3):142-6. PubMed ID: 7048691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria].
    Kurita Y; Kageyama S; Ishikawa A; Ushiyama T; Ohta N; Suzuki K; Kawabe K
    Hinyokika Kiyo; 1994 Jun; 40(6):479-83. PubMed ID: 8073954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients].
    Glémain P; Prunet D
    Prog Urol; 2006 Nov; 16(5):542-5. PubMed ID: 17175947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hydrochlorothiazide, allopurinol and magnesium oxide in the treatment of recurrent calcium urolithiasis].
    Musialik D; Głuszek J; Pieczyńska A
    Pol Tyg Lek; 1991 Oct 7-21; 46(40-42):739-42. PubMed ID: 1669148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for biochemical abnormalities in urolithiasis patients.
    Orakzai N; Hanbury DC; Farrington K
    J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of allopurinol in the prevention of recurrent calcium oxalate stones].
    Sonoda T; Koide T; Oka T; Sakaguchi H; Itatani H; Ohkawa T; Ebisuno S; Morimoto S; Yoshida O; Okada Y
    Hinyokika Kiyo; 1985 Nov; 31(11):2071-9. PubMed ID: 4091144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing the course of calcium oxalate stone disease.
    Tiselius HG
    Eur Urol; 1999 Nov; 36(5):363-70. PubMed ID: 10516443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allopurinol and thiazide effects on new urinary stone formed after discontinued therapy in patients with urinary stones.
    Kohri K; Kodama M; Katayama Y; Ishikawa Y; Takada M; Kataoka K; Katoh Y; Iguchi M; Kurita T
    Urology; 1990 Oct; 36(4):309-14. PubMed ID: 2219608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind study with thiazide in recurrent calcium lithiasis.
    Scholz D; Schwille PO; Sigel A
    J Urol; 1982 Nov; 128(5):903-7. PubMed ID: 7176047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hydrochlorothiazide in the metaphylaxis of recurrent calcium oxalate lithiasis].
    Bick C; Brien G; Fahlenkamp D; Koch R
    Z Urol Nephrol; 1982 Nov; 75(11):753-8. PubMed ID: 7164602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.